A novel TNKS/USP25 inhibitor blocks the Wnt pathway to overcome multi-drug resistance in TNKS-overexpressing colorectal cancer.
Journal Information
Full Title: Acta Pharm Sin B
Abbreviation: Acta Pharm Sin B
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Pharmacology & Pharmacy
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflicts of interest The authors declare no potential conflicts of interest."
"This study was financially supported by the National Key Research and Development Program of China (2022YFC2804100, 2021YFF0502400, 2022YFC2804300); National Natural Science Foundation of China (82073713, 22137006, 82104033, 82173730, 81903499, 32070070, 82160669); Innovative research team of high-level local universities in Shanghai (SHSMU-ZDCX20212702, China). We thank Dr. Juncheng Su from Shanghai Jiao-Tong University School of Medicine (Shanghai, China) for providing the LoVo and COLO 320DM cell lines."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025